Disclosures: Harshavardhan Sanekommu: Nothing to Disclose, Vera Hapshy: Nothing to Disclose, Christopher Schreiber: Nothing to Disclose, Talal Bhatti: Nothing to Disclose, Lee Peng: Nothing to Disclose 1327 ANXIETY AND DEPRESSION ARE SIGNIFICANTLY ASSOCIATED WITH WORSE HEALTH-RELATED QUALITY OF LIFE IN LIVER TRANSPLANT SURVIVORS Alexander Scherer 1 Umer Bhatti 2 Qing Tang 1 Christine Abeysekera 3 Miranda Stovall 1 Rachel Holmes 1 Anahli Patel 1 Eric Orman 2 Lauren Nephew 2 Marwan Ghabril 2 Chandrashekhar Kubal 1 Naga Chalasani 4 Archita Desai 1 , 1 Indiana University School of Medicine, 2 Indiana University, 3 Indiana University Indianapolis, 4 Indiana University Medical Center Background: The prevalence of mental health disorders (MHDs) in liver transplant (LT) survivors is significantly higher than in the general population
Evidence type: Human RCT | Observational | Animal | In vitro | Regulatory Mechanism of Action The Tesamorelin + Ipamorelin blend acts on two complementary axes of the somatotropic system
Mandatory pre-treatment health screening and post-infusion clinical review for every patient, with full medical documentation maintained in compliance with NMC record-keeping standards
Our findings thus suggest that Ant2-deficient T cells bypass the typical metabolic reprogramming required for activation, leading to enhanced T cell function and highlighting the therapeutic potential of targeting ANT for immune modulation
